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BACKGROUND: Classically, multiple myeloma patients have been susceptible to encapsulated organisms, primarily S. pneumoniae and H. influenzae. Over the past several decades, the incidence of gram-negative infection in patients with multiple myeloma has increased to almost 60% in some reports. Autologous stem cell transplantion, with its aggressive, myelosuppressive chemotherapy and need for indwelling central venous catheters, is increasingly used to manage the disease. We undertook this study to define the pathogens causing bacteremia in patients with multiple myeloma in this era. METHODS: The study included 80 consecutive multiple myeloma patients with a positive blood culture between 1996 and 2002. A retrospective review of medical records defined demographic and clinical information at the time of the positive blood culture. Demographic information included: age, sex, and home zip code. Clinical information included: CBC, creatinine, calcium, 2 microglobulin, C-reactive protein, LDH, location of bone lesions, use of opiates, corticosteroids, use and type of chemotherapy, presence of central venous catheters, and time of death. RESULTS: The average age of our multiple myeloma patients was 60 with a gender frequency of 60% male. Percent with renal function impairment (creatinine >1.3 mg/dl) and hypercalcemia (>10.5 mg/dl) were 50% and 2.5%, respectively. Approximately 64% ultimately died of complications related to multiple myeloma. 110 bacterial isolates were identified in 99 positive blood cultures. Gram-positive cocci accounted for 69% of all isolates, 30% due to coagulase-negative Staphylococcus, 9% S. pneumoniae, 8% S. aureus, 6% S. viridans, 5% hemolytic streptococcus, and 5% E. faecium. Coagulase-negative Staphylococcus was associated with the presence of an indwelling central venous catheter 76% of the time. Enteric gram-negative organisms accounted for 18% of all isolates and consisted of 10% E.coli, 5% K. pneumoniae, and 3% P. aeruginosa. Only 1 case of H. influenzae was identified during the study period. CONCLUSION: After decades of increased gram-negative bacteremia in patients with multiple myeloma, we observed a strong resurgence of gram-positive organisms. The majority was due to coagulase-negative Staphylococcus and were associated with use of central venous catheters. Even excluding bacteremias related to a central catheter, the majority of bacteremias were due to a variety of gram-positive bacteria. The change in the pathogens responsible for bacteremia in our study likely reflect both the impact of aggressive treatment regimens, requiring placement of central venous catheters, and immunosuppression from high dose chemotherapy. BACKGROUND: Measurement of serum C-reactive protein (CRP), a widely available marker of systemic inflammation, has been proposed as an exclusionary test for pulmonary embolism (PE). Our goal was to evaluate the diagnostic accuracy of CRP testing alone and combined with clinical probability assessment in outpatients with suspected PE, and to compare its performance to a well-documented D-dimer assay. METHODS: Between December 2000 and January 2002, we performed a standard immunoturbidimetric CRP (DAKO Rabbit Anti-Human) and a rapid enzyme-linked immunosorbent assay (ELISA) D-dimer test (VIDAS DD, BioMe Ârieux) in 259 consecutive outpatients with suspected PE at the emergency department of a teaching hospital. We assessed clinical probability of PE by a validated prediction rule. Patients with D-dimer levels (z 500 g/l underwent a diagnostic work-up consisting of lower-limb venous ultrasound, spiral computerized tomography, ventilation-perfusion scan, or pulmonary angiography. All patients were followed up for 3 months. We calculated sensitivity, specificity, and predictive values for the CRP and the D-dimer test at a cut-off level of 5 mg/l and 500 g/l, respectively. RESULTS: Seventy-seven (30%) of the patients had objectively confirmed PE after the 3-month follow-up. The CRP test alone had a sensitivity of 84% (95% confidence interval [CI] : 74 to 92%) and a negative predictive value (NPV) of 87% (95% CI: 78 to 93%) below a cut-off level of 5 mg/l. Of the 116 (45%) patients with a low clinical probability of PE, 61 (24% of the total cohort) had a CRP < 5 mg/l. In this subgroup, the NPV of a CRP < 5 mg/l increased to 97% (95% CI: 89 to 100%). A D-dimer < 500 g/l showed a sensitivity of 100% (95% CI: 95 to 100%) and a NPV of 100% (95% CI: 94 to 100%) irrespective of clinical probability, thus ruling out PE in 56 (22%) patients. Both the CRP and the D-dimer test had a low specificity of 44% (95% CI: 37 to 52%) and 31% (95% CI: 24 to 38%), respectively. CONCLUSION: An ELISA D-dimer is a better exclusionary test than a CRP assay in outpatients with suspected PE. CRP assays without additional information should not be used to exclude PE. However, CRP testing may be useful in combination with clinical probability assessment if ELISA D-dimer assays are not available. Further studies are needed to examine the role of CRP in the diagnosis of PE. BACKGROUND: On weekends, many departments in hospitals tend to have lower staffing levels which may affect patient care. We evaluated the availability of seven selected urgent procedures for emergently hospitalized patients and tested for delays based upon the day of admission. METHODS: We analyzed all acute care admissions from emergency departments in Ontario, Canada, between 1988 and 1997 . We selected patients (n = 130,461) who underwent one of seven prespecified procedures felt by health records technologists to represent the most responsible procedure occurring during their hospitalization. We chose procedures requiring skill that from our clinical experience, were often associated with substantial in-hospital delays. These were: fiberoptic bronchoscopy, esophageal gastroduodenoscopy, magnetic resonance imaging, echocardiography, ventilation perfusion scanning, administration of chemotherapy, or coronary angiography. We noted each patient's day of hospital admission, as well as the day of the week that the procedure was performed. We also compared proportions of procedures delivered to expected ratios and analyzed time to procedure based upon the day of hospital admission. RESULTS: Only 5% (6,279) of the urgent procedures were performed on the weekend. Of the seven procedures, coronary angiography showed the most skewed pattern of procedural performance (1.5% performed on the weekend) and administration of chemotherapy showed the least skewed pattern (10% performed on the weekend). For all seven procedures, the mean time from admission to most responsible procedure was 3.7 days. Patients admitted on weekends had a longer mean procedural wait in days compared to patients admitted on weekdays (3.9 vs 3.6, P < 0.001). CONCLUSION: Few urgent procedures are performed in emergently hospitalized patients on the weekend, resulting in longer waits for those admitted to hospital on the weekend. Greater attention to weekend care might result in immediate improvements in hospital efficiency. BACKGROUND: Antibiotic-induced nephrotoxicity is a frequent occurrence in the inpatient hospital setting. Elderly patients may be at particularly high risk because of decreased renal function. Calculation formulae and other reference tools can guide appropriate dosing, but are inconsistently used. We sought to determine the frequency of inappropriate antibiotic dosing in an inpatient elderly population, and explore factors that may contribute to dosing errors. METHODS: All patients 64 years or older admitted to the General Medicine teaching service during 1 month at our institution were eligible. Those who were placed on fluoroquinolones, macrolides, vancomycin, and beta-lactams were studied by retrospective chart review. Aminoglycosides were excluded because of the high frequency of once-daily dosing. The following information was abstracted: (1) initial antibiotic dosing (to minimize the effect of attending or pharmacist input), (2) patient age, (3) gender, (4) weight, and (5) most recent serum creatinine (SCr). Glomerular filtrate rate (GFR) was approximated as the Creatinine Clearance (CCr ), estimated by the Crockoff-Gault formula: CCr = (gender factor) Â [(140± Age) Â weight]/(SCr Â 72). We then determined the appropriateness of the initial dose for each patient by comparison to that recommended by 2 independent reference tools (one local, one national). Patients were stratified into risk categories based on 4 factors: (1) age, (2) gender, (3) weight, and (4) SCr. Multiple logistic regression was performed using these risk factors as independent variables, and appropriateness of the dose as the dependent variable. RESULTS: One hundred patients met eligibility criteria for review. Of these, 38% were incorrectly dosed (97% of these were over-dosed We searched for studies employing pulmonary angiography or ventilation/ perfusion(V/Q) scintigraphy as the reference standard. Paired reviewers assessed the study quality of eligible articles in a systematic and independent fashion, and abstracted data. RESULTS: Fives studies met inclusion criteria and were reviewed. All participants in each study were enrolled because of suspicion of acute PE. Four of the five studies enrolled fewer than 40 patients each. The sensitivity of MRA ranged from 77 to 100%, and specificity ranged from 62 to 100%. The use of MRA for detecting emboli in more distal pulmonary arterial segments was lower than in proximal vessels. CONCLUSION: The evidence suggests that contrast enhanced pulmonary MRA may be both sensitive and specific for detecting pulmonary emboli in lobar and segmental branches of the pulmonary arteries. Larger studies are indicated to confirm these findings in a representative population. BACKGROUND: Recent reports highlighting medical errors have spurred numerous patient safety initiatives, but these initiatives may fail if they are not supported by providers. Our purpose was to determine what measures increased the utilization of a controversial patient safety initiative at our institution. METHODS: We performed a retrospective review of administrative and medical records at a university-affiliated tertiary care hospital to compare utilization of a patient safety initiative before versus after various measures were undertaken to increase its use. The initiative established a response team that could respond emergently to grave clinical deterioration with the aim of preventing cardiac arrests. The effort to increase its use was led by an established hospital committee that had a directive to promote patient safety, and began after medical record review suggested that the team was underutilized despite high levels of hospital staff education. We used linear regression analysis to compare utilization before versus after each measure was adopted. We also compared utilization rates of the main alternative response strategy (STAT pages in rapid succession). RESULTS: The baseline rate of team responses was 32.2 per month (95% CI 27.0±37.8) and baseline rate of alternative responses was 6.2 per month (95% CI 4.3±8.1). Four measures were introduced over 15 months; two involved individual feedback to caregivers and their supervisors if they failed to utilize the team response when it was medically appropriate, and two involved creating and disseminating objective criteria for team response utilization. Both of the individual feedback measures were followed by small nonsignificant increases in team utilization (2.5 and 2.2 additional responses per month respectively), and neither significantly affected utilization of the alternative strategy. However, the objective criteria measures, introduced simultaneously, were followed by large and statistically significant increases in team responses (19.2; 95% CI 12.1±26.3; p < 0.0001), and were also followed by decreases in use of the alternative response (À5.7 per month; 95% CI À3.2 to À8.2; p < 0.0001). CONCLUSION: Controversial initiatives that are initially underutilized may be used appropriately if objective criteria guiding their use is established and disseminated. BACKGROUND: Sparse data from hospitals in Australia and Great Britain suggest that some cardiac arrests may be prevented through a team response to the severe clinical deterioration that often precedes arrests, in addition to the standard``code'' team responses once cardiac arrests occur. Our purpose was to investigate whether protocol-based utilization of this type of team (Medical Crisis Response Team) at a US hospital was followed by decreases in the incidence and mortality of cardiac arrests. METHODS: At our university-affiliated tertiary care hospital, a medical crisis response team had existed for several years, but was underutilized based on medical record review. A protocol was adopted in an effort to increase its utilization, and this was followed by a rapid and significant increase in the number of medical crisis team responses. In the present study, we compared cardiac arrest incidences and outcomes before versus after utilization of the response team increased. Fatal cardiac arrest was defined as death during the calendar day of the arrest. Rates are per 1000 admissions. Utilization rates for medical crisis response team did not include responses to cardiac arrests. The organization of the response team was similar tò`c ode'' teams for cardiac arrests. RESULTS: Over the 21month period of study, there were 1,299 medical crisis team responses and 322 cardiac arrests. Medical crisis response team utilization rose from 13.1 per 1000 admissions before protocol implementation to 24.7 per 1000 admissions after (p < 0.0001). There was a concomitant decline in the incidence of fatal cardiac arrests (2.6 per 1000 before versus 1.6 per 1000 after, p = 0.008), cardiac arrests overall (6.0 per 1000 versus 4.9 per 1000, p = 0.08), and a decrease in the proportion of arrests with fatal outcomes (44.5% versus 33.3%, p = 0.06). The incidence of cardiac arrests without survival to discharge also decreased (3.3 per 1000 versus 2.9 per 1000, p = 0.27); however the proportion of cardiac arrests without survival to discharge did not change noticeably (56% versus 59%). CONCLUSION: Implementation of a protocol for responding to medical crises is feasible in a US tertiary care hospital, and may be associated with fewer and less fatal cardiac arrests. BACKGROUND: It remains unclear if good perioperative control of diabetes reduces shortterm mortality and morbidity. The aims of our analysis were to determine if mean or peak glucose levels were independently associated with 30-day mortality and or morbidity. METHODS: We performed a retrospective cohort study of consecutive diabetic patients receiving insulin therapy undergoing coronary artery bypass surgery or valvular heart surgery. We analyzed data that were collected at Robert Wood Johnson University Hospital for the Society of Thoracic Surgeons national database and that were supplemented with additional information including pre, and post-operative glucose levels. The primary composite outcome was defined as postoperative 30-day mortality, myocardial infarction or infection (pneumonia, septicemia, superficial or deep sternal wound infection, or leg/arm harvest site infection). Two composite secondary outcomes were also evaluated: mortality and morbidity (primary outcome, renal failure, stroke/TIA, ARDS, and multisystem failure), and cardiac outcome (myocardial infarction, congestive heart failure or 30 day mortality). We defined postoperative glucose levels in four ways: average glucose level within 3 and 7 days of surgery, and peak glucose levels highest levels within 3 and 7 days of surgery. We used logistic regression to adjust for age, gender, type of surgery, history of diabetic complications (nephropathy, neuropathy, or retinopathy), and history of renal failure. RESULTS: 500 patients were included in the study; 421 underwent isolated coronary artery bypass surgery. The mean (standard deviation) glucose levels were: average 3 day-213 (35), average 7 day-205 (33), peak 3 day-335 (71), peak 7 day-352 (72). The primary outcome occurred in 9.8%. Mortality and morbidity occurred in 15.8%, and cardiac outcomes occurred in 6.0%. Average 3 day and 7 day glucose levels were not associated with any of the outcomes. However, in both unadjusted and adjusted models, 3 and 7 day peak glucose levels were associated with most of the outcomes. For every 50 mg/dl change in 3 day peak glucose levels, the adjusted odds ratio (95% confidence interval) for the primary outcome was 1.16 (0.95± 1.42), for mortality or morbidity was 1.25 (1.05±1.47), and for cardiac outcomes was 1.35 (1.06±1.72). For every 50 mg/dl change in 7 day peak glucose levels, the adjusted odds ratio (95% confidence interval) for the primary outcome was 1.27 (1.04±1.55), for mortality or morbidity was 1.38 (1.16±1.64), and for cardiac outcomes was 1.27 (0.99±1.62). CONCLUSION: Increases in 50 mg/dl in peak glucose levels were associated with 16%-38% increases in mortality and morbidity in diabetic patients receiving insulin therapy. In contrast, we found no evidence that average glucose levels were associated with postoperative mortality and morbidity. Clinical trials are needed to confirm that lowering peak glucose levels improves outcomes in cardiac surgical patients. BACKGROUND: Many efforts have been made to improve outcomes and to reduce utilization, but few have worked to do both among a broad spectrum of general medical inpatients. Our studies have shown that patients who are moderately ill with fair to poor function have worse outcomes and resource utilization. OBJECTIVE: The objective of this randomized trial among moderately ill medical inpatients who had fair to poor function on admission was to reduce iatrogenic complications (falls, new decubitus ulcers, and pneumonia) and reduce length of stay. Our hypothesis was that outcomes could be improved simultaneously reducing costs by shifting resources to patients at greater risk. METHODS: Patients who were moderately ill with fair to poor function at admission were identified through a computer program that intern's used to sign-out to each other. All 1,037 such patients admitted to the medical floors over a 5 month period were evaluated within 24 hours with instruments developed and validated to identify patients who required early intervention by social work, physical therapy (PT), occupational therapy (OT) and/or psychiatry.
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Of the 612 eligible, and 444 patients were randomized either to usual care or to receive early intervention by social work, PT, OT or psychiatry based on the screening instruments RESULTS: 58% of patients were female, with an average age of 68 and median comorbidity score of 2. Equal proportions of patients in both randomization groups needed early intervention for social work (77%), PT (75%), OT (45%) and psychiatry (28%). The early intervention group received more social work evaluations (77% vs. 61%) and effectively double the rates for PT (23% vs. 60%), OT (44% vs. 15%) and Psychiatry (22% vs. 11%). The delay between admission and intervention for each of the services was cut by about 50% Ð from 3.2 to 1.6 days for social work, from 6 to 3.1 days for PT, from 7.5 to 3.6 days for OT, and from 5.5 to 2.9 days for Psychiatry.Iatrogenic complications were decreased in the early intervention group 7.3% vs. 13.8% in the usual care group (p = .042). Specifically, falls decreased from 7.5% to 4.6%, pneumonia from 3.1% to 1.8% and new decubitus ulcers from 4.8% to 2.3%. Among patients who were triggered for interventions (whether or not they received them), the early intervention group had an overall LOS 0.7 days lower and a LOS variance was 0.9 days lower than the usual care group (ns BACKGROUND: Venous thromboembolism (VTE) is common in hospitalized medical patients (~20% incidence). VTE prophylaxis in these patients has been shown to be efficacious and is recommended as standard of care. Recently published data suggests, however, that VTE prophylaxis in this subgroup of patients is markedly underutilized. In addition, adherence with national guidelines for VTE prophylaxis on the medical wards of a large inner-city university affiliated hospital remains underreported. The objective of our study was to determine the rate of utilization of VTE prophylaxis in hospitalized medical patients and to assess the efficacy of an intervention designed to help increase this utilization. METHODS: Step1: We collected data regarding indications, contraindications, and utilization of VTE prophylaxis (within 24 hours of admission) in medical patients admitted to a large public hospital over one month.
Step 2: We then conducted a series of educational sessions directed at housestaff, attending physicians, clinical pharmacists and care/clinical managers regarding the need for VTE prophylaxis and appropriate regimens. Also, we developed a new standard admission orders form with pre-printed options for VTE prophylaxis on it.
Step 3: After this intervention we went back to the wards and collected another set of data using the same data collection sheet. RESULTS: Out of 204 medical patients studied initially, 148 had indications and no contraindications for VTE prophylaxis. The pre-intervention utilization rate of VTE prophylaxis was 32% (47 of 148 eligible patients received prophylaxis). After intervention, out of 196 studied patients, 158 had indications and no contraindications for prophylaxis. The postintervention utilization rate of VTE prophylaxis went up to 53% (84 of 158 eligible patients). CONCLUSION: Our results suggest that: 1. VTE prophylaxis among medical patients admitted to a large inner city academic hospital is indeed underutilized. 2. Simple educational interventions and availability of VTE prophylaxis options on standard admission orders can significantly increase the utilization of VTE prophylaxis in this setting. BACKGROUND: Recent studies have shown the critical importance of early application of interventions designed to reduce infarct size in acute myocardial infarction (AMI). Significant delay in starting treatment may result in increased necrosis and more severe manifestations of AMI. This in turn may lead to more intensive treatment and longer length of stay (LOS). We sought to test the hypothesis that distance from the patients' residence to the hospital they were admitted for AMI (DIST) affects treatment intensity and LOS. METHODS: We examined all Medicare hospitalizations with AMI as principal diagnosis extracted from Medicare records for 1998 excluding cases with DIST>100 miles. An AMI admission within one day of a discharge after an AMI was considered a transfer and was merged with initial record. The final analytical sample consisted of 286,542 cases. For each distance category we calculated average LOS, LOS top-coded to 30 days (LOS30), and percentage of cases with LOS>30 days (LOS>30). Patients were categorized into 4 groups according to most intensive procedure: coronary artery bypass graft surgery (CABG), percutaneous transluminal coronary angioplasty (PTCA) without CABG, cardiac catherization (CATH) without PTCA or CABG, or none of these three procedures (NoPROC). RESULTS: Comparison across distance categories, based on 2 d tests of independence and analysis of variance, followed by tests of pairwise comparisons, showed statistically significant differences between DIST = 0±25 and all other distance categories for all outcome variables (p < 0.001). Adjusting for patient age, sex, race, type of hospital (including procedure volume) through multiple regression analysis yielded similar results. The differences in procedure volume in different distance categories remained significant after 90 days since admission. CONCLUSION: Patients with AMI living further from the hospital are more likely to have more intensive treatment and longer hospital stays. BACKGROUND: National guidelines for patients hospitalized with community-acquired pneumonia (CAP) recommend treatment with a beta-lactam antibiotic plus a macrolide or doxycycline. Doxycycline is an attractive alternative to a macrolide given its spectrum of antibacterial activity, low cost, and concern over increasing rates of macrolide resistant S. pneumoniae. We evaluated the effectiveness of ceftriaxone plus doxycycline (C+D) in patients hospitalized with CAP. METHODS: A retrospective cohort of adults discharged between 1/99 and 7/01 at a large academic medical center with a principal diagnosis of CAP were analyzed by chart review. Patients with post-obstructive pneumonia, immunosuppression, cystic fibrosis, or recent hospitalization were excluded. Initial antibiotic regimen was based on the first 48 hours of hospitalization. To adjust for confounding by indication, a propensity score based on comorbid illness, admission from nursing home, aspiration pneumonia and intensive care unit admission was included in multivariable models measuring the association between C+D and inpatient and 30-day mortality. RESULTS: Of the 539 patients eligible for analysis, 216 (40%) received C+D. Other common initial empiric regimens included beta-lactam/lactamase inhibitor (BLI) monotherapy (n = 73,14%), and 2nd / 3rd generation cephalosporin monotherapy (n = 55, 10%). Compared to patients treated with other regimens, patients treated with C+D had a similar median age (76 vs. 75 yrs, P = 0.53), but a lower median pneumonia severity index (PSI) score (97 vs. 109, P < 0.0001), lower inpatient mortality (2.3% vs. 14.6%, P < 0.0001), and lower 30-day mortality (6% vs. 22%, P < 0.0001). The propensity score had fair predictive ability for the use of C+D with an area-under-the-ROC curve of 0. BACKGROUND: Serum levels of C-reactive protein (CRP) are greatly increased by severe bacterial infections such as pneumonia, only modestly increased by viral respiratory tract infections, and are independent of age. We compared the performance of a rapid, bedside serum CRP test with a clinical prediction rule for identifying pneumonia in adults with acute cough illness. METHODS: Adults seeking care for acute respiratory tract infections (symptoms <3 weeks) in the emergency or urgent care department at an urban, academic medical center were recruited for study between January and April 2002. Exclusion criteria included systemic and acute conditions associated with elevated CRP levels. A standardized encounter form was used to record clinical information. Whole blood CRP levels were measured on a fingerstick blood specimen using the NycoCard Reader II (Axis-Shield, Norway). Providers were blinded to these test results. The clinical prediction rule for pneumonia of Heckerling, et al, was calculated for each patient. Physician-designated pneumonia diagnosis was the primary outcome. Multivariable logistic regression was used to calculate area-under-the-ROC curve (c-statistic), and measure independence of associations. RESULTS: Among adults with acute cough illness (n = 246), 25 (10%) were diagnosed with pneumonia (20 confirmed by chest radiography). Patients diagnosed with pneumonia were older (median age 56 vs. 33 yrs, p < 0.001), and were more likely to have abnormal vital signs (74% vs. 27%, p < 0.001) and an abnormal chest exam (80% vs. 13%, p < 0.001). Median CRP levels were significantly higher for patients diagnosed with pneumonia compared to nonpneumonia (58 mg/L vs. 11 mg/L, p < 0.0001). The area-under-the-ROC curves for predicting pneumonia by CRP and the clinical prediction rule were 0.82 and 0.84, respectively. CRP levels and the clinical prediction rule were independently associated with pneumonia, yielding a combined area under the ROC curve of 0.92. CONCLUSION: The performance of CRP in adults with acute cough illness suggest that this test could be a valuable addition to existing clinical prediction rules for pneumonia, and may supplement these rules by distinguishing viral from non-viral pneumonia. BACKGROUND: Glycemic control in the intensive care unit is very important. We did a retrospective chart review of patients in the ICU who had elevated blood sugar levels (>200 mg/dl). This was done in a community based tertiary referral hospital with 475 beds in central Illinois. The surrounding population encompases close to 300,000 people including the rural areas. The hospital has 8 medical ICU beds, 8 surgical ICU beds and cardiac, neurological, and intermidiate bed capacity. The intervention taken to control these blood sugars was also investigated. It was found that consistently elevated blood sugars were treated in various ways and with suboptimal control achieved. It is the goal of this review to demonstrate that better glycemic control is needed. METHODS: A list glucometer readings with patient identification numbers was obtained from a seven month period of time this past year. A random retrospective chart review of twenty patients who were in the ICU from January 2002 to July 2002 was done. The only requirement was that blood sugars had to be above 200 mg/dl on two seperate occasions. No specific admitting diagnosis was inlcuded or excluded. The main criteria examined was: whether they carried an additional diagnosis of diabetes, steriods were used, total parentral nutrition (TPN) used and what type of agent to control the elevated blood sugar was implemented. Additional data gathered was: what final outcome the patient had and an average range blood sugars they had while in the ICU. RESULTS: Common admitting diagnosis were: respiratory distress, pnuemonia, heart failure and stroke. Twelve people were female and five were male. Average age was 62 years old. Additionally 12 people carried the diagnosis of diabetes, 10 people required steriods, 3 required TPN, 11 went home, 6 went to a nursing home, and 2 died. Average range of blood sugars in all patients were from 120±306 mg/dl with all of the patients requiring some type of insulin (short or long acting). Most commonly, an insulin sliding scale (regular or humalog) was used in 15 patients. Initiation of a longer acting insulin was done in five patients. None had an insulin drip initiated. All patients still maintained an elevated blood sugar of >120 mg/dl even with the initaition of insulin. And the range of blood sugar was not improved. CONCLUSION: The wide range of blood sugars in this ICU setting demonstrates a need for a protocol to help acheive better and tighter control even in such a small subset of patients studied. All of the methods used (ie sliding scales and long acting insulin) were suboptimal in this critical care population. It is the thought of the authors that the Implementation of a standard method such as an insulin drip will help achieve better tighter range control. The developement and implementation of an insulin drip will be studied in a future cohort. BACKGROUND: The empirical management of patients with the aseptic meningitis syndrome is controversial. METHODS: We conducted a prospective observational study of adult patients (age >16 yrs) with meningitis (CSF WBC >5) with a negative Gram stain presenting to the Emergency Departments of three tertiary care hospitals in New Orleans between 11/99 and 12/02. RESULTS: Seventy-four adults with a mean age of 39 [18 ± 95] were enrolled in the study. 51% of the study participants were female and 77% were African American. 69% were immunocompetent; but 32% had a Charlson comorbidity score of more than 1, and 20 (27%) had HIV or AIDS. 20% patients had recently taken antibiotics and 15% reported taking NSAIDs at the time of enrollment. Only 10% reported recent contact with an ill person. The most frequently reported presenting symptoms were headache (82%), fever (73%), neck stiffness (50%) and photophobia (43%). 26% of patients presented with a focal neurologic deficit or seizures. The physical exam revealed fever in 47%, abnormal mental status in 31%, nuchal rigidity in 26%, focal neurologic findings in 19% and skin rash in 9% of the patients. The median CSF white blood cell count was 64 [6 ± 9375], median CSF protein was 73 [24 ± 1438] and median CSF glucose was 51 [0 ± 316]. The majority of patients (90%) underwent a CT scan and 16% had an MRI. 25% of the CT scans and 42% of the MRI scans were found to be abnormal. 77% of patients were admitted to the hospital, 78% received empiric antibiotic therapy, and 19% received empiric antiviral therapy in the emergency department. 58 (78%) patients had an unknown etiology, 14 (19%) patients were diagnosed with an urgent treatable etiology, the most common being bacteremia [E.coli (1), Streptococcus pneumoniae (1), Staphylococcus aureus (3)], 4 patients had cryptococcal meningitis, 2 patients had bacterial meningitis [Listeria monocytogenes (1), E. faecalis (1)], one patient had Herpes simplex encephalitis, and one patient had Varcella zoster meningitis. One patient was diagnosed with a subarachnoid hemorrhage. 2 (3%) patients had untreatable etiologies [Enterovirus (1), EBV (1)]. Elevated CSF protein (>40 mg/dl) (p = 0.048) and decreased CSF glucose (<45 mg/dl) (p = 0.020) were found to be significantly associated with an urgent treatable etiology. Abnormal mental status (p = 0.531), and elevated CSF granulocyte count (p = 0.879) were not significant predictors. CONCLUSION: Elevated CSF protein and decreased CSF glucose are significant predictors for an urgent treatable condition in patients with aseptic meningitis syndrome. BACKGROUND: We have reported that patients managed with symptom-triggered therapy (STT) for Alcohol Withdrawal Syndrome (AWS) on general medicine services had a decreased incidence of delirium tremens (DTs) compared to historical controls. There was no difference between intervention and control cohorts in the total dose of benzodiazepines (BZD), expressed as lorazepam equivalents. We hypothesized that a change in utilization of long-and short-acting BZD may have contributed to the observed decrease in DTs. METHODS: Pre-and post-implementation cohorts were defined as definite AWS patients managed two years before and after implementation of STT . Choice of BZD remained with the prescribing MD. All clinical and pharmacologic data were obtained by chart review. Longacting BZD (chlordiazepoxide, clonazepam, diazepam) dose was defined as an equivalent to oral lorazepam (using accepted conversion ratios) received during the duration of treatment. The associations of treatment group and long-acting BZD equivalents and use of long-acting BZD were assessed with mixed-models analysis of covariance, using generalized estimating equations to account for multiple admissions for the same patient. We adjusted for Charlson Comorbidity Index, age, sex, prior AWS, prior withdrawal seizures, and prior DTs. RESULTS: The average (SD) long-acting BZD dose received (expressed as oral lorazepam equivalents) was 18.2 (18.0) in the pre-implementation cohort and 11.1 (9.8) in the postimplementation cohort (p = 0.026). Long-acting BZD were received by 58 (69%) patients in the pre-implementation cohort and 45 (34%) patients in the post-implementation cohort (p < 0.001). CONCLUSION: Patients treated with STT were less likely to receive long-acting BZD and received lower doses of long-acting BZD than pre-implementation controls. We believe that careful clinical monitoring in an STT approach as well as more frequent use of short-acting BZD contributed to our observed decrease in DTs. BACKGROUND: There is a high degree of military and civilian sexual trauma among male and female Veterans. This leads to an increased prevalence of PTSD, anxiety, depression, substance abuse, suicidality, sexual problems among the Veteran population. There is a strong association between childhood sexual abuse and future sexual victimisation among both males and females screened. METHODS: 110,000 patients were screened for sexual trauma from 1/1/02 to 9/30/02 at VAMC Northport. Of these 700 patients were female and the rest male. They were asked about the age at which it first occured, sex of the perpetrators and if there was more than one episode of abuse. RESULTS: 305 patients reported sexual trauma, 200 of whom were female and 105 male. Of these 60% of females and 50% of males reported sexual abuse as children. The median age at which victimisation occured was 9.9 for males and 6 for females. 20% of females and 10 % of males reported multiple episodes of abuse. BACKGROUND: As reperfusion therapy, primary coronary intervention (PCI) has been shown to yield superior outcomes to thrombolytic therapy in acute myocardial infarction (AMI). Yet in most settings thrombolysis remains the standard of care. Starting with the Thrombolytic Predictive Instrument (TPI) that makes real-time, patient-specific predictions of outcomes with thrombolytic therapy, we sought to add estimates of the expected incremental benefits of PCI compared to thrombolytic therpay, and also estimates of the procedure-related delay that would nullify these benefits. METHODS: We developed a database of 3006 patients who received either thrombolytic therapy or PCI for AMI from both registry and clinical trial data. We used this database to modify the TPI's logistic regression equations in order to make predictions for patients treated either with thrombolytic therapy or with PCI, the``Reperfusion TPI'' (R-TPI). We then validated the R-TPI on an independent dataset (The C-PORT Trial). RESULTS: In addition to the TPI equation, the new predictive model required variables to account for the differential treatment impact of PCI (compared to thrombolytic therapy), an interaction between PCI-effect and baseline TPI risk, door-to-treatment time, and a new variable for age. Predictions were then obtained on patients in the C-PORT trial with complete data (n = 337). The mean predicted mortality for those in the thrombolysis arm was 6.3% (observed 6.0%). The mean predicted mortality for the PCI arm was 4.5% (observed 3.9%). The area under the ROC on this validation dataset was 0.87. There was considerable variation in the expected incremental benefit of PCI compared to thrombolytic therapy across this population. Similarly, the door-to-balloon time expected to nullify this benefit ranged from 0.3 to 4.3 hours (h) (median 1.7h, interquartile range 1.3h ± 2.3h). CONCLUSION: The R-TPI accurately predicts mortality in patients with AMI receiving either PCI or thrombolysis. Installed in an electrocardiograph as is the TPI, such an instrument may be useful in selecting which patients benefit most from PCI compared to thrombolytic therapy, potentially in the pre-hospital setting so that such patients might be brought to angioplasty-capable centers. BACKGROUND: Only about 2% of patients with acute ischemic stroke receive thrombolytic therapy, largely due to its narrow therapeutic time-window (within 3 hours of symptom-onset). We sought to develop a model that might be useful in selecting patients with a favorable riskbenefit profile for therapy even after the approved time window. METHODS: We combined the individual patient data of trials testing rt-PA in acute ischemic stroke (NINDS 1 and 2, ATLANTIS A and B, ECASS 2). We divided this database (n = 2022) into development (n = 1348) and test (n = 674) datasets. Using logistic regression, we created a model on the development data set predicting good outcomes (modified Rankin Score <= 1) with and without rt-PA therapy. Using this model and pre-treatment characteristics, we divided patients treated after 3 hours (in the development dataset) into those expected to benefit (favorable profile) and those expected to be harmed (unfavorable profile) by rt-PA therapy and examined the actual outcomes in these groups. RESULTS: Predictors of outcome include stroke severity, age, diabetes, serum glucose and rt-PA therapy. The effect of rt-PA was modified by gender, systolic blood pressure and symptom-onset to treatment time. Using this model and pretreatment patient characterisitcs, 24% of patients treated between 3 and 6 hours were predicted to be harmed and 76% were predicted to benefit from rt-PA therapy. While their was no benefit for rt-PA overall, there was substantial benefit in patients with a favorable profile (Table) . CONCLUSION: Multivariable risk-benefit profiling may be useful in the meticulous selection of stroke patients for rt-PA therapy after 3 hours. This model should be validated on the test dataset and prospectively tested. BACKGROUND: The blood levels of lipid and apolipoprotein were determined in 403 subjects for the sake of evaluating the gender difference in the association of blood lipid with coronary heart disease. METHODS: In the total subjects studied, there were 233 cases with coronary heart disease (CHD group) and 170 healthy individuals (control group). Gender subgroups were further divided in each group. RESULTS: (1) Blood levels of TC; TG; LDL-C and Lp(a) were significantly higher and HDL-C level was lower in both female and male CHD groups compared with the corresponding gender control group. (2) In comparison with males, the blood levels of TC; LDL-C and HDL-C were significantly higher in females in both CHD cases and healthy controls. But the difference in the ratio of TC to HDL-C was not significant. (3) The indices such as HDL-C, TC, hypertension, age and apoB were the independent predictors for the risk of CHD in males, while only HDL-C and hypertension were the independent risk factors for CHD in females. CONCLUSION: The gender difference of blood lipids mades the association of lipid with CHD somewhat different in females from in males. In the evaluation of CHD risk in females, special attention should be paid to blood HDL-C level, because it is usually higher than that in males. BACKGROUND: Current guidelines for acute coronary syndromes (ACS) suggest the use of the TIMI Risk score for non-ST elevation myocardial infarction (nSTEMI) and unstable angina (UA) ACS's as a prognostic tool to guide therapy. The objective of this study is to validate this tool in a generalist-run community hospital. METHODS: The charts of all patients admitted with chest pain to the Sault Area Hospital, (SAH) a community hospital in Northern Ontario, were reviewed. SAH is 350 km away from the nearest hospital, and the Ontario Cardiac Care Network tracks revascularization procedures and outcomes. Data abstraction included all demographics and clinical characteristics needed for the calculation of the TIMI risk score, complete 14 day outcomes and the use of various medications in individual patient cases. RESULTS: From May 2001±April 2002, 817 patients were admitted to SAH with chest pain. The cohort consisted of 614 patients diagnosed with NSTEMI/UA ACS and 73 patients with non-cardiac diagnoses. The TIMI score accurately discriminated among low, medium and high-risk categories. However, the observed rate of composite outcomes was significantly higher than predicted by TIMI. Despite a high composite 14-day rate of death, MI and urgent revascularization in the combined medium-and high-risk groups (122/300, 40.7%), there was a low rate of the use of clopidrogel (48.3%), low-molecular weight heparin (61.0%) and Gp2b3a inhibitors (0%). CONCLUSION: The TIMI risk score for NSTEMI/UA ACS is a valid prognostic tool in the community hospital, and might even be useful to help improve the use of certain therapeutic agents in the appropriate setting. BACKGROUND: Some 4.2 million patients with diabetes are hospitalized each year in the United States. Poor glycemic control has been shown to adversely affect the outcomes of patients hospitalized with myocardial infarction, stroke, and for a variety of surgical procedures, yet glycemic management often receives little attention from hospital-based physicians. We sought to characterize current glycemic management strategies and to identify opportunities to improve glycemic control. METHODS: We reviewed the medical records of patients with diabetes mellitus who were admitted to a regular medical, cardiology or surgical bed for treatment of a problem other than diabetes at a large community based teaching hospital between January 1 and February 28th 2002. We identified each patients home regimen, the hospital-based glycemic management strategy and the results of regularly scheduled glucose measurements for up to 4 days of hospitalization. We calculated rates of moderate and severe hyperglycemia and hypoglycemia. RESULTS: Of the 160 patients with diabetes who were hospitalized during the study period 89 (56%) were treated on the medical service, 43 (27%) on surgery and 27 (13%) on cardiology. 61 (38%) were receiving treatment with sulfonylureas, 29 (18%) with metformin, 25 (16%) with TZDs and 47 (29%) with insulin in the outpatient setting. The median admission glucose was 181 (IQR 131±248). In 79 (61%) patients the home regimen was continued at full strength, in 30 (23%) it was reduced and in 20 (15%) it was stopped entirely. Sliding scale insulin regmimens were employed in 113 (78%) of the patients treated with hypoglycemic medications in the hospital. The most common glycemic management strategies were sliding scale alone (21%), oral agent + sliding scale (21%), NPH insulin + sliding scale We obtained a total of 1366 Medwatch reports, which yielded 988 individual cases of rhabdomyolysis. Cerivastatin was associated with 523 cases, simvastatin 254, atorvastatin 100, pravastatin 76, lovastatin 41, and fluvastatin 11 (some patients used multiple statins). Of these cases, 81.0% resulted in hospitalization, 13.2% led to renal dialysis, and 8.1% died. Cerivastatin patients had a case-fatality rate of 4.4% compared to 12.0% in non-cerivastatin patients (RR = 0.4; 95% CI: 0.2±0.6). Concomitant use of a fibrate drug occurred in 53.5% of cerivastatin users and 12.4% of all other patients (RR = 4.3; 95% CI: 3.3±5.5). Among reports with adequate dates (n = 506), cerivastatin recipients had a median exposure time of 30.5 days from starting the drug to the onset of rhabdomyolysis, compared to a median of 203.5 days for all other cases (p < 0.0001; Wilcoxon Rank Sum). Among 722 patients with laboratory data, cerivastatin patients had a median peak CPK of 35,000 IU/L, whereas the median peak CPK of all other patients was 15,664 IU/L (p < 0.0001; Wilcoxon Rank Sum). CONCLUSION: Cerivastatin-related incidents of rhabdomyolysis accounted for the majority of cases in our study period. Cerivastatin cases had lower case-fatality rates, higher proportions of concomitant fibrate use, shorter time between initiation of statin therapy and onset of symptoms, and higher peak CPK values. The more indolent course and higher case-fatality rate among the non-cerivastatin users demand increased vigilance for the symptoms of rhabdomyolysis in statin-treated patients. BACKGROUND: Aluminium phosphide is a solid fumigant pesticide widely used in the Indian subcontinent as a grain preservative.It accounts for over 15,000 cases of poisoning annually and is the most common cause of chemical suicide in Northern India. Cases of aluminium phosphide overexposure have also been reported from Australia, UK and USA. Severe metabolic acidosis is common and histopathology of various organs showed changes suggestive of cellular hypoxia. However,the exact mechanism, treatment and prognostic value of metabolic acidosis has not been well established. METHODS: The study material comprised of 30 patients of aluminium phosphide poisoning who came in a state of shock (systolic BP < 80 mm mg) and showed frank clinical evidence of aluminum phosphide toxicity. Detailed general and systemic examination was done at the time if admission. All the patients received supportive treatment in the form of oxygen, positive ionotropic suppor, antiarrythmic treatment etc. Arterial blood gas analysis was done at the time of admission after 3 hrs, 6 hrs and subsequently 24 hrs according to which sodium bicarbonate was given to correct the deficit. RESULTS: Low blood pH and gross bicarbonate deficit (severe acidosis ) were a consistent finding in all the patients. The mean pH and bicarbonate level of the series were 7.11 0.137 and 12.52 4.22. Overall 13 out of 30 patients died with a total mortality rate of 43.3%. Mortality was highest in patients with pH < 7.0. Mean sodium bicarbonate required to correct acidosis was 299.66 197.85. Acidosis could be corrected in 18 out 30 patients. Only 1 out of these 18 patients died while all the 12 remaining patients whose acidosis could not be corrected died. The other prognostic indicators were the total number of alumunium phosphide tablets ingested and the time of sythesis of these tablets. CONCLUSION: Our primary observation on 30 patients indicates that severe acidosis is a consistent feature of acute aluminium phosphide poisoning. Correction of acidosis by calculated dose of sodium bicarbonate improves survival. Non-improvement in blood pH following use of sodium bicarbonate is a bad prognostic indicator. BACKGROUND: Community-acquired pneumonia (CAP) is the seventh leading cause of death in the US and the leading cause of infectious death. Several national clinical practice guidelines have recommended specific antimicrobial regimes for patients with CAP however there is controversy whether the use of these regimes is associated with improved outcomes. Our aim was to determine the association between the use of guideline-concordant antimicrobial therapy and 30-day mortality in patients with CAP. METHODS: A retrospective, observational study was conducted at a two tertiary teaching hospitals: a VA medical center and a county-run referral hospital. Eligible patients were admitted with a diagnosis of CAP between 1/1/2000 and 12/31/2001, had a chest x-ray consistent with CAP, and had a discharge ICD-9 diagnosis of pneumonia. Patients were excluded if they were``comfort measures only'' or transferred from another acute care hospital. Severity of illness was quantified using the Pneumonia Severity Index (PSI). A step-wise forward logistic regression analysis was performed using 30-day mortality as the dependent measure, and the PSI, whether antibiotic therapy was guideline-concordant, and any other variable significant to p < 0.1 in the univariate analysis, as the independent variables. RESULTS: Information was obtained on 420 patients with CAP. The median age was 63 years, 85% were male, and 20% were initially admitted to the ICU. By PSI, 45% were low risk, 35% were moderate risk, and 20% were high risk. Mortality was 9.8% at 30-days. The antibiotics were concordant with national guidelines in 88% of patients±93% of medical ward and 66% of ICU patients. The most frequent non-guideline concordant antibiotics used were monotherapy with fluoroquinolones in ICU patients. In the regression analysis, after adjustment with the PSI, only non-guideline concordant antibiotic therapy (odds ratio with 95% CI 3.0, 1.2±7.2) was associated with 30-day mortality. CONCLUSION: Using antibiotic regimens that are not guideline-concordant was associated with increased 30-day mortality for patients hospitalized with CAP. Patients hospitalized with CAP should receive antimicrobial regimes concordant with national published guidelines, and prospective studies are needed to examine the influence of choice of antimicrobial therapy on patient outcomes. BACKGROUND: Maintaining compliance with recommended antidepressant treatment is a common and long-standing concern in medical practice. Although 70% to 90% of patients with major depressive disorder respond to the first or second antidepressant prescribed, approximately 50% discontinue medication before 90 days, 67% terminate prematurely because of side effects, and only 10% to 15% complete the recommended 4 to 6 months of acute continuation phase treatment. Serotonin reuptake inhibitor (SRI) antidepressant± associated sexual dysfunction (SD) occurs in 25% to 75% of patients and is a principal independent factor leading to treatment failure. The purpose of this study was to determine whether the effectiveness of sildenafil citrate treatment for SD is maintained during continuation of antidepressant management and consequently supports continued depression in remission and improved treatment outcomes. METHODS: 90 men with depression in remission and SRI-associated SD on stable-dose antidepressant were randomized to double-blind treatment with sildenafil (50 mg-100 mg adjustable) or placebo for 6 weeks. With blind maintained, the responders discontinued sildenafil for 3 weeks and on determining reappearance of SD, received 8 additional weeks of open-label sildenafil. Double-blind partial responders or nonresponders (Clinical Global Impression, CGI > 2) repeated the initial 6-week course with open-label sildenafil and then entered the 8-week extension. Outcome measures included the International Index of Erectile Function, UNMSexual Function Inventory, CGI±Sexual Function (CGI-SF), and Hamilton Depression Scale. RESULTS: Sildenafil treatment resulted in significant improvement in all SD domain scores in the double-blind phase (effect size, 1.07; 95% CI 0.77±1.37) and persisted through the 24 study weeks; 38/40 (95%) initial partial responders or nonresponders significantly improved (CGI-SF < 2) during the open-label extension. Hamilton Depression Scale scores remained <10, with no depression relapses or recurrences observed. CONCLUSION: Sildenafil effectively reversed SRI-associated SD, allowing adherence and persistence of effective SRI antidepressant dose to maintain depression in remission. These data support the need to focus on adverse event management for improving disease outcomes. BACKGROUND: Depression, erectile dysfunction (ED) and antidepressant treatment frequently occur together. ED is also likely to occur with other comorbid conditions such as diabetes, hypertension, cardiovascular disease; the treatment for these conditions; or lifestyle risk factors. When ED is a symptom or side effect of medications for these conditions, patients are frequently noncompliant in order to retain their sexual function and consequently risk relapse, recurrence, or exacerbation of the condition. METHODS: Sildenafil citrate has demonstrated broad-based effectiveness in treating ED of wide-ranging etiologies. We review and compare the results of 3 randomized, placebocontrolled trials and 1 retrospective analysis of data pooled from 10 clinical trials that examined the efficacy of sildenafil in treating ED associated with depression and as an adverse effect of serotonin reuptake inhibitor (SRI) antidepressant treatment. RESULTS: These clinical trials indicate that sildenafil is highly effective in treating patients with ED associated with depressive symptoms, ED caused by SRI antidepressant treatment, residual ED with onset associated with prior antidepressant treatment, and ED caused by independent etiologies in patients taking concurrent SRIs. In each of these studies, sildenafil was effective for ED (primary measure) in addition to other associated domains of sexual dysfunction. CONCLUSION: Despite the complex relationships among ED, depression, SRIs, and associated conditions, sildenafil is effective independent of specific etiology. Thus, a comprehensive evaluation, including sexual function, an accurate differential diagnosis, and effective treatment of the determined primary condition with a stable medication dose, is a prerequisite to proper ED management with sildenafil. BACKGROUND: The purpose of this study was to evaluate the extent to which patient expectations predict perceived functional improvements for patients treated for shoulder problems and to assess whether patients' initial shoulder function moderated the relation between baseline expectations and shoulder function outcome. In addition, we examined how patients' baseline expectations and shoulder function changes over three months predicted patients' perceptions of fulfilled expectations. METHODS: Patients (n = 199) treated at one orthopedic surgeon's office completed a baseline survey comprised of measures of patient expectations, shoulder function, health status, and demographics. At one month, two months, and three months, patients completed a mailed follow-up survey comprised of all baseline measures except demographic variables. At three months, a measure of expectation fulfillment was added. A general linear modeling approach was used to assess the significance and effect size (R2) of (1) BACKGROUND: Low health literacy is common in the US and is associated with poor health status. In patients with asthma, low health literacy has been identified as a barrier to adequate asthma-related knowledge, including metered-dose inhaler (MDI) technique. We therefore conducted a study to determine asthma medication knowledge and its relationship to health literacy following an intensive education program in a high-risk adult population. METHODS: Eighty adults hospitalized for asthma exacerbation at two urban medical centers were enrolled. Participants were asked about demographics, asthma-related acute care utilization in the past 12 months (emergency department or hospitalizations), history of intubation, and to complete the Short Test of Function Health Literacy in Adults (STOFHLA: 0±22 low literate, 23±36 functionally literate) and the Cognistat test for cognitive impairment. We conducted a 1-on-1, hour-long, guideline-based, written and oral educational intervention at hospital discharge. Following instruction, patients were asked about their asthma medication schedule using a standardized survey and asked to demonstrate use of MDI. The number of times it took patients to exhibit knowledge of their medication regimen and MDI technique was recorded. RESULTS: The mean age was 42 years (range 19±69); 62% were female, 84% were African American, 34% had not attained a high school diploma, and 67% reported an annual household income of less than $20,000. Over the past 12 months, the mean number of emergency room visits and hospitalizations was 4.9 (range 0±24) and 2.5 (range 0±14) respectively. Fully 44% reported a history of intubation. 30, 2002 . The 4 services rotate admissions on a 1 in 4 day cycle, and consist of an attending, a senior resident and two interns. For each patient discharge (n = 2617), data were obtained on length of stay (LOS), Diagnosis Related Group (DRG), DRG-weight, inpatient mortality and 14-day readmission rate. To reduce skew, cases with a LOS greater than 3 standard deviations above the mean were excluded. Attendings were grouped as hospitalists (3 or greater months/year of inpatient work) and non-hospitalists, as well as by specialty [general medicine (n = 16), rheumatology (n = 8), nephrology (n = 5), and endocrinology (n = 3)]. We used either linear or logistic regression with adjustment for casemix and employed robust variance estimates to adjust for clustering at the level of attending. Other analyses examined the DRG-based diagnoses of pneumonia, renal failure, and connective tissue diseases, comparing LOS and patient outcomes by physician specialty. RESULTS: There was a significant increase in average LOS of 0.6 days (95% CI, 0.2 to 1.0; P = 0.003) for rheumatologists (4.6 days) compared to general internists (4.0 days); there was no significant difference in readmission rate or mortality. There was also a significant increase in average LOS for endocrinologists (0.4 days [CI, 0.1 to 0.7]; P = 0.01) compared to general internists. No signficant difference in LOS was seen between general internists and nephrologists (À0.2 days [CI, À0.6 to 0.3]; P = 0.5). In addition, there were no significant differences in LOS by physician specialty for the specific DRG-based diagnoses. We saw a non-statistically significant trend towards reduced LOS for hospitalists (À0.3 days [CI, À0.65 to 0.04 days]; P = 0.08) compared to non-hospitalists. CONCLUSION: Patients cared for by rheumatologists and endocrinologists stayed in the hospital significantly longer than similar patients cared for by general internists without any significant differences in clinical outcomes. We also observed a trend towards reduced LOS without differences in outcomes for hospitalists compared to non-hospitalists. We conducted a prospective study of 38 patients who require long-term oral anticoagulation therapy with coumadin for DVT, PE or A.Fib. Participants were randomly selected. We excluded those patients who had known liver disease, elevated liver enzymes or using medications that can affect coumadin level. 21 patients were randomly started on high dose (10 mg) and 17 were started on low dose (5 mg) of coumadin and maintenance doses were given according to the INR level. The total dose of coumadin required and number of days for INR to be therapeutic range were calculated in both group of patients. RESULTS: Average length of stay in all patients was 7.10 days. Average length of stay in patients receiving high dose coumadin was 6.85 days vs. 7.40 days in patients receiving low dose coumadin. 50% of patients who were started on high dose achieve therapeutic INR inBACKGROUND: Increased rates of early readmission and length of stay (LOS), quality of care indicators for hospital systems by Medicare peer review organizations, suggest suboptimal discharge planning and poor overall health care delivery. This review aims to determine the effect of comprehensive discharge planning compared with usual care on the rate of early readmission, initial LOS and acute medical costs. METHODS: We searched MEDLINE, the Cochrane Clinical Trials Register and other databases for reports of clinical trials comparing the effect of comprehensive discharge planning with usual care on rates of early readmission, initial LOS and acute medical costs in adult patients, mean age > 18, hospitalized with chronic medical conditions. We selected English language publications of randomized controlled trials in adult patients who were acutely hospitalized with chronic medical conditions, with a detailed description of discharge planning and reporting data for readmission within 1-month and/or one of the following outcomes: LOS and acute medical costs Two the authors independently reviewed each published report, assigned a quality score based on previously validated methods, and abstracted data relevant to the inclusion criteria. Only one meta-analysis for the effect of discharge planning on rates of early readmission was possible using a random effects model. Data for LOS and acute medical costs are presented as average values/per patient. RESULTS: 9 trials enrolling 2721 patients met all the inclusion criteria. Compared with patients receiving usual care, patients receiving comprehensive discharge planning had fewer readmissions (relative risk 0.62 [95% Confidence Interval 0.44, 0.86], p < 0.05, N = 9 trials); similar median LOS (9.1 vs. 8.7 days, p > .05) respectively; and no significant increase in acute medical costs ($8,294 vs. $7,570 , N = 5, p > .05). Effective comprehensive discharge planning includes: individualized assessment of functional status and the need for social services after hospital discharge (N = 9), intensive education to patients and their caregivers to enhance self management of chronic illness (N = 8), review and simplification of medications prior to discharge (N = 5), timely and appropriate communication with the primary care physicians and, scheduling timely ambulatory follow-up and/or arranging for post discharge support (N = 7). CONCLUSION: Comprehensive discharge planning reduced rates of early readmission without increasing costs for acute medical care or delaying hospital discharge. Further research is needed to determine whether this intervention is as efficacious for surgical patients. BACKGROUND: Previous studies have shown that use of hospitalists is associated with shorter average lengths of stay (LOS). What precisely drives this efficiency is unknown. As hospitalist models include mostly recent graduates, efficiencies may be related to more junior status. We examined whether patients of more recent graduates had shorter LOS. METHODS: All inpatient admissions during 2001 to the Department of Medicine at a community-based, tertiary care teaching hospital were assessed, via an administrative database, for attending of record, attending's year of medical school graduation, patient LOS and principal DRG as coded by trained chart abstracters. Each admission was categorized as being above or below the particular DRG's national mean LOS as reported by Medicare. This deviation from the mean was reported as percent above or below the national mean. Each DRG's deviation, weighted for the number of admissions within that DRG, were summed for each attending. In this way we computed an overall average deviation from the mean for all of his/her admissions. We grouped attendings as being either less than or greater than 20 years from medical school graduation. Mean deviation for each group was compared by student's t-test. RESULTS: One hundred and six attendings were within 20 years of graduation while 105 were beyond 20 years. More recent graduates were a median of 14.5 years out of medical school, while less recent graduates were a median of 27 years out. There were 6,620 admissions by the more recent graduates and 5,952 by the less recent graduates. Patients of the more recent graduates had LOS 7% below the national mean on average (À7%), while patients of the less recent graduates had LOS 5% above the national mean on average (+5%). This difference was statistically significant (p = 0.03). CONCLUSION: We found evidence that patients admitted by more recent medical school graduates had shorter LOS. By comparing summed deviations from the national mean for each of their patients' principal DRG we attempted to control for case-mix. The 12% difference noted between groups of attendings approximates the increased efficiencies noted through hospitalists. It is possible that some of the efficiencies seen in hospitalist models are accounted for by hospitalists' younger age. Perhaps recent graduates were taught different practices in terms of when a patient is stable for discharge and what investigations and treatments are safe to pursue in the outpatient arena. The specific practices that result in these efficiencies, whether mediated by the hospitalist model or more recent training remain to be elucidated. BACKGROUND: General internal medicine may be evolving toward separate career paths for outpatient and inpatient care. Physician stress and dissatisfaction from attempting to balance inpatient and outpatient care may, in part, underlie increases in the numbers of hospitalists and exclusively outpatient-oriented providers. We thus used data from a national physician survey to ask: Among outpatient-oriented general internists (i.e., who spend <50% of their clinical time caring for inpatients), what effect does time spent in the hospital have on physician satisfaction, stress, and burnout? METHODS: We used the Physician Worklife Study, in which 5704 physicians randomly selected from the AMA's Masterfile were surveyed (response rate = 52%). We focused on fulltime outpatient-oriented general internists (n = 339). We constructed multivariate linear models to test for significant associations between time spent seeing inpatients and physician satisfaction as measured by several satisfaction scales. We hypothesized that time in the inpatient setting would decrease administration, job, and personal time satisfaction, while increasing stress levels. Covariates included physician age, gender, race, marital status, income, and total hours worked per week.
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RESULTS: 23% of respondents were women, 63% were white; mean age was 47 years. Increased time in the hospital was significantly associated with decreased satisfaction with administration, specialty, autonomy, and personal time and an increase in stress (Table) . There was a positive association between increased hospital time and burnout. CONCLUSION: As time spent in the hospital increases, physician satisfaction in several important domains decreases. Our results suggest that outpatient-oriented providers become increasingly dissatisfied with increasing inpatient time and thus may be more willing to relinquish day-to-day care of their inpatients to hospitalists. Of thesè`r epeat-after-a-positive'' tests, 12 (42.9%) were done in the first 48 hours, 7 (25%) where done after 3±7 days, and 10 (35.7%) were done in the next 8±14 days. CONCLUSION: C. difficile stool toxin test is ordered in more than 1 out of 20 patients admitted to our hospital, and is positive in 12.4% of patients tested. Despite minimal clinical value and published recommendations that it not be done, the test is not infrequently repeated. Most repeat tests cluster around the 1st two days of the initial positive test, suggesting that this duplicate testing stems largely from logistical issues related to physician ordering, nurse specimen collection, and laboratory delivery. The remaining inappropriate orders are likely generated by misdirected``test-of-cure,'' or faulty diagnostic strategies in evaluating patients with persistent diarrhea. Both the laboratory (related to duplicate specimens) and physician ordering practice interventions are warranted to minimize these unnecessary tests.
